My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

uniQure N.V. - Ordinary Shares (NQ:QURE)

23.43 -0.97 (-3.98%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about uniQure N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

Crude Oil Rises 2%; LumiraDx Shares Spike Higher ↗

June 21, 2023

U.S. stocks traded lower toward the end of trading, with Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.04% to 34,040.13 while the NASDAQ fell 0.77% to 13,562.00. The S&P...

Via Benzinga

Where uniQure Stands With Analysts ↗

June 21, 2023

Via Benzinga

Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 21, 2023

Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...

Via Benzinga

Why uniQure Stock Is Crashing Today ↗

June 21, 2023

Investors are focusing on the negative parts of the biotech company's interim results.

Via The Motley Fool

6 Analysts Have This to Say About uniQure ↗

May 11, 2023

Via Benzinga

Analyst Ratings for uniQure ↗

March 07, 2023

Via Benzinga

Why UniQure Shares Are Plummeting Today? ↗

August 08, 2022

Via Benzinga

Nasdaq Tumbles 1%; Patterson Companies Earnings Beat Views ↗

June 21, 2023

U.S. stocks traded mostly lower midway through trading, with Nasdaq Composite dropping over 100 points on Wednesday.

Via Benzinga

Uniqure Crashes To Six-Year Low On Muddy Results For Huntington's Gene Therapy ↗

June 21, 2023

The company is working on a one-time treatment for Huntington's disease.

Via Investor's Business Daily

Dow Drops Over 100 Points; Winnebago Industries Posts Downbeat Sales ↗

June 21, 2023

U.S. stocks traded lower this morning, with Dow Jones dropping over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.41% to 33,914.60 while the NASDAQ fell 0.31%...

Via Benzinga

uniQure's Hemgenix Royalty Sales Agreement Extends Cash Runway, Relieves Near-Term Commercial Risk, Says Analyst ↗

May 15, 2023

uniQure N.V. (NASDAQ: QURE) agreed to sell a portion of the royalty rights due from CSL Behring from Hemgenix (etranacogene dezaparvovec-drbl) net sales to HealthCare Royalty and Sagard Healthcare

Via Benzinga

Recap: uniQure Q1 Earnings ↗

May 09, 2023

uniQure (NASDAQ:QURE) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:05 AM. Here's what investors need to know about the announcement. Earnings uniQure missed estimated earnings by...

Via Benzinga

Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs ↗

March 10, 2023

New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per...

Via Benzinga

uniQure Stock Trying To Close In On Key Technical Measure ↗

February 28, 2023

uniQure stock had its Relative Strength Rating upgraded to 79 Tuesday -- a nice improvement, but still shy of the 80-plus desired score.

Via Investor's Business Daily

uniQure To Rally Around 162%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

February 28, 2023

UBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a Sell rating. Honeywell shares fell 0.2% to $191.99 in pre-market...

Via Benzinga

UniQure In-Licenses Early-Stage Amyotrophic Lateral Sclerosis Candidate, Analyst Says Deal Compliments Its Pipeline ↗

January 31, 2023

UniQure N.V. (NASDAQ: QURE) and Apic Bio entered into a global licensing agreement for APB-102 to treat superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS).

Via Benzinga

3 Growth Stocks That Could Rocket Higher in 2023 ↗

January 06, 2023

Upcoming binary events could push these stocks to new all-time highs.

Via The Motley Fool

Newly Approved Drugs In US Command Over $200,000 On An Average ↗

January 05, 2023

The median annual price of 17 new drugs approved by the FDA since July 2022 reached $193,900, down from $257,000 in 1H of 2022. For the full year 2022, the median price was $222,003.

Via Benzinga

Have A Look At William Blair's Top Biotech Picks For 2023 ↗

December 25, 2022

William Blair & Company's report outlined some key themes and significant trends to monitor while entering 2023, providing its top stock ideas for the upcoming 12-month period.

Via Benzinga

Why Shares of uniQure Rose 14.61% on Wednesday ↗

November 23, 2022

A big approval for a gene therapy sent the biotech's stock higher.

Via The Motley Fool

The FDA Just Approved The Most Expensive Drug Ever — Sending UniQure Stock On A Warpath ↗

November 23, 2022

And shares of its developer are on a warpath this week.

Via Investor's Business Daily

FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults ↗

November 23, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

November 25, 2022

On Friday, 68 companies reached new 52-week highs.

Via Benzinga

uniQure: Q3 Earnings Insights ↗

November 02, 2022

uniQure (NASDAQ:QURE) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings uniQure beat estimated earnings by...

Via Benzinga

Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday ↗

November 25, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.

Via Benzinga

Roblox's Stock Gets A Price Target Cut By This Analyst; Also Check Out Some Other Major PT Changes ↗

August 09, 2022

Truist Securities boosted the price target on Roblox Corporation (NYSE: RBLX) from $29 to $45. However, Truist Securities analyst Matthew Thornton maintained the stock with a Hold. Roblox shares fell...

Via Benzinga

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗

August 09, 2022

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

Via Benzinga

Nasdaq Turns Lower; Crude Oil Rises Over 1% ↗

August 08, 2022

U.S. stocks pared gains toward the end of trading, with the S&P 500 and the Nasdaq turning lower on Monday.

Via Benzinga

Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

August 08, 2022

Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...

Via Benzinga

Dow Jumps Over 150 Points; Karuna Therapeutics Shares Spike Higher ↗

August 08, 2022

U.S. stocks traded higher this morning, following the release of strong jobs data on Friday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.